Page last updated: 2024-10-23

azathioprine and Hematemesis

azathioprine has been researched along with Hematemesis in 1 studies

Azathioprine: An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed)
azathioprine : A thiopurine that is 6-mercaptopurine in which the mercapto hydrogen is replaced by a 1-methyl-4-nitroimidazol-5-yl group. It is a prodrug for mercaptopurine and is used as an immunosuppressant, prescribed for the treatment of inflammatory conditions and after organ transplantation and also for treatment of Crohn's didease and MS.

Hematemesis: Vomiting of blood that is either fresh bright red, or older coffee-ground in character. It generally indicates bleeding of the UPPER GASTROINTESTINAL TRACT.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ehmsen, L1
Marko, C1
Breidert, M1

Other Studies

1 other study available for azathioprine and Hematemesis

ArticleYear
[Portal vein hypertension during azathioprine therapy in patients with Crohn's disease--a frequent phenomenon?].
    Deutsche medizinische Wochenschrift (1946), 2008, Volume: 133, Issue:18

    Topics: Azathioprine; Crohn Disease; Enbucrilate; Esophageal and Gastric Varices; Focal Nodular Hyperplasia;

2008